European Medicines Agency widens access to its documentsBMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c7039 (Published 07 December 2010) Cite this as: BMJ 2010;341:c7039
- Rory Watson
The London based European Medicines Agency is preparing to make more of its documentation available to health professionals and the general public. The initiative is in response to increasing demand for information and to criticism earlier this year by the ombudsman for the European Union after the agency refused two requests for access to documents it held.
Announcing the new policy guidelines, Noël Walthion, the head of patient health protection at the agency, said, “Openness and transparency are enshrined as fundamental values in the agency’s regulatory framework. They allow our stakeholders to understand the basis for the agency’s scientific decision …